HLA matching effect in liver transplantation.
D016572:Cyclosporine / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology / Q000401:mortality; D006680:HLA Antigens / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality; D016853:Muromonab-CD3 / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D015996:Survival Rate; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D016559:Tacrolimus / Q000008:administration & dosage
D006680:HLA Antigens; D016853:Muromonab-CD3; D016572:Cyclosporine; D011241:Prednisone; D016559:Tacrolimus